Magnus Nordenskjold
Overview
Explore the profile of Magnus Nordenskjold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
3525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiang S, Covill L, Tesi B, Campbell T, Schlums H, Nejati-Zendegani J, et al.
Blood
. 2024 Jul;
144(8):873-887.
PMID: 38958468
Primary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder associated with autosomal recessive variants in genes required for perforin-mediated lymphocyte cytotoxicity. A rapid diagnosis is crucial for successful treatment. Although defective...
2.
Wang S, Elmgren J, Eisfeldt J, Asad S, Ek M, Bilcha K, et al.
JID Innov
. 2024 Jun;
4(4):100284.
PMID: 38859976
Loss-of-function variants in the gene have been identified as the strongest cause of susceptibility to atopic dermatitis (AD) in Europeans and Asians. However, very little is known about the genetic...
3.
Sivars L, Jylha C, Crona Guterstam Y, Zupancic M, Lindqvist B, Nordenskjold M, et al.
Clin Cancer Res
. 2024 Apr;
30(13):2764-2771.
PMID: 38669077
Purpose: Human papillomavirus (HPV) is the cause of the majority of cervical cancer cases and has been showed to be released as cell-free tumor DNA (ctHPV DNA) into the circulation....
4.
Arthur C, Carlson L, Svoboda J, Sandvik U, Jylha C, Nordenskjold M, et al.
NPJ Precis Oncol
. 2024 Feb;
8(1):44.
PMID: 38388693
Midline CNS tumors are occasionally inaccessible for surgical biopsies. In these instances, cell-free DNA (cfDNA) may serve as a viable alternative for molecular analysis and identification of targetable mutations. Here,...
5.
Paucar M, Laffita-Mesa J, Niemela V, Malmgren H, Nennesmo I, Lagerstedt-Robinson K, et al.
J Neurol Sci
. 2023 Jun;
451:120707.
PMID: 37379724
Objective: To perform a screening for Huntington disease (HD) phenocopies in a Swedish cohort. Methods: Seventy-three DNA samples negative for HD were assessed at a tertiary center in Stockholm. The...
6.
Caron V, Chassaing N, Ragge N, Boschann F, Ngu A, Meloche E, et al.
Genet Med
. 2023 Apr;
25(8):100856.
PMID: 37092537
Purpose: Dominant variants in the retinoic acid receptor beta (RARB) gene underlie a syndromic form of microphthalmia, known as MCOPS12, which is associated with other birth anomalies and global developmental...
7.
Arthur C, Jylha C, Diaz De Stahl T, Shamikh A, Sandgren J, Rosenquist R, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046633
Medulloblastoma is a malignant embryonal tumor of the central nervous system (CNS) that mainly affects infants and children. Prognosis is highly variable, and molecular biomarkers for measurable residual disease (MRD)...
8.
Wallander K, Haider Z, Jeggari A, Foroughi-Asl H, Gellerbring A, Lyander A, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831507
In this longitudinal study, cell-free tumour DNA (a liquid biopsy) from plasma was explored as a prognostic biomarker for gastro-oesophageal cancer. Both tumour-informed and tumour-agnostic approaches for plasma variant filtering...
9.
Sivars L, Hellman K, Crona Guterstam Y, Holzhauser S, Nordenskjold M, Falconer H, et al.
Gynecol Oncol
. 2022 Aug;
167(1):107-114.
PMID: 35918201
Objectives: Tumor cells release fragments of their DNA into the circulation, so called cell-free tumor DNA (ctDNA) or liquid biopsy. Here, we analyze if cell-free human papillomavirus DNA (ctHPV DNA)...
10.
Arthur C, Rezayee F, Mogensen N, Saft L, Rosenquist R, Nordenskjold M, et al.
Front Oncol
. 2022 Jul;
12:899325.
PMID: 35865473
Risk-adapted treatment in acute lymphoblastic leukemia (ALL) relies on genetic information and measurable residual disease (MRD) monitoring. In this proof of concept study, DNA from diagnostic bone marrow (BM) of...